SF3B1 and B-cell chronic lymphocytic leukemia: Differential gene expression between CLL cells with and without SF3B1 mutation/del(13q) indicated the upregulation of the MYC target pathway and downregulation of the inflammatory pathway (Supplemental Figure 4A), consistent with the role of these 2 lesions in the murine model.